Press Releases & Statements

Investor Relations

Month Year

Month Year

Novavax Hosts HM King Carl XVI Gustaf and HM Queen Silvia of Sweden During Royal Visit to Uppsala County
- COVID-19
Sep 24, 2021
Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinical Trial Published in The Lancet Infectious Diseases
- Seasonal Influenza
Sep 23, 2021
Novavax and Serum Institute of India Announce Submission to World Health Organization for Emergency Use Listing of Novavax' COVID-19 Vaccine
- COVID-19
Sep 23, 2021
Novavax to Participate in Fireside Chat at the 2021 Cantor Virtual Global Healthcare Conference
- Corporate and Finance
Sep 23, 2021
Novavax to Participate in Fireside Chat at Devex @ UNGA 76
- COVID-19
Sep 20, 2021
Novavax Statement on Proof of COVID-19 Vaccine Requirements for PREVENT-19 Clinical Trial Participants in the U.S.
- Statement
- COVID-19
Sep 17, 2021
Novavax to Participate in University of Oxford Com-COV3 Study Comparing Mixed COVID-19 Vaccine Schedule in Adolescents
- COVID-19
Sep 16, 2021
Novavax Statement on Takeda Agreement to Provide 150 Million Doses of NVX-CoV2373 to the Government of Japan
- Statement
- COVID-19
Sep 10, 2021
Novavax to Participate in Upcoming September Conferences
- Corporate and Finance
Sep 9, 2021
Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza
- COVID-19
Sep 8, 2021

Show per page